Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)
Clinical trial NCT01844518 · COMPLETED
Trial details
- NCT number
- NCT01844518
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-30
- Primary completion
- 2015-03-12
- Enrollment
- 219
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.